Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vicept Therapeutics, Inc.
With
Accenture
Patients must have moderate to severe erythematous (facial redness) rosacea
* Male and female patients must be at least 18 years old and in good general health
* Female patients must not be pregnant or nursing
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
male or females at least 18 years of age
diagnosis of stable erythematous rosacea
\< 3 inflammatory lesions
in good general health
females must be non-pregnant and non-lactating
must be willing to sign a consent form
You may not be if
have ocular, phymatous or other types of rosacea
allergy to any ingredient in study drug
participation in other investigational studies within 30 days of enrollment
use of systemic steroids within 28 days of Baseline
use of tetracycline antibiotics within 28 days of baseline
use of products containing oxymetazoline within 14 days of baseline
use of topical steroids witin treatment area 14 days prior to baseline
use of Rx or OTC products for treatment of acne or rosacea within 14 days of baseline
use of any product for reducing redness within the treatment area witin 14 days prior to baseline
use of monoamine oxidase (MAO) inhibitors
use of niacin \>/= 500mg/day
Clareo Health | Dose Response Study of Patients With Erythematous Rosacea
